Exact Sciences' Q4 Revenues Flat, Loss Widens
February 20, 2013
Exact Sciences' Q4 Revenues Flat, Loss Widens
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Exact Sciences Posts Flat Q2 Revenues
July 28, 2010 / GenomeWeb Daily News - Exact Sciences' Q1 Revenues Up on Genzyme Payment; Cuts Loss
May 6, 2010 / GenomeWeb Daily News - License Fees Help Exact Sciences Cut Q4 Net Loss
February 16, 2010 / GenomeWeb Daily News - Exact Sciences Expects to Raise $64M in Public Offering of Stock
June 18, 2013 / GenomeWeb Daily News - MDx/CDx Focus: Exact Finishes Cologuard Submission; Natural Molecular Launches Cardiac Test on xMAP
June 12, 2013 / Pharmacogenomics Reporter